天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

1-Methylindoline-4-carboxylic acid

1-Methylindoline-4-carboxylic acid Struktur
168899-63-6
CAS-Nr.
168899-63-6
Englisch Name:
1-Methylindoline-4-carboxylic acid
Synonyma:
1-Methylindoline-4-carboxylic acid;1H-Indole-4-carboxylic acid, 2,3-dihydro-1-methyl-
CBNumber:
CB92616936
Summenformel:
C10H11NO2
Molgewicht:
177.2
MOL-Datei:
168899-63-6.mol

1-Methylindoline-4-carboxylic acid Eigenschaften

Siedepunkt:
365.9±35.0 °C(Predicted)
Dichte
1.246±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
2.95±0.20(Predicted)

Sicherheit

1-Methylindoline-4-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

1-Methylindoline-4-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-Methylindoline-4-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 40)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63687 58
KARMEL TECHNOLOGY (HK) CO.,LIMITED
+8618795957998
karmelhk@126.com CHINA 2886 58
CR Corporation Limited
+8613062833949
fred.wen@crcorporation.cn China 8647 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131957 58
Wuhan TCASChem Technology Co., Ltd. 027-027-86697669 13986148687
sales@tcaschem.com China 3881 55
Chengdu AstaTech Trading Co., Ltd./AstaTech (Chengdu) Pharma. Co., Ltd. +86-28-85122536 85324413
market@astatech.cn China 8026 55
Shanghai CR Corporation Limited 021-80270511; 4006653949
fred.wen@crcorporation.cn China 10044 58
Hangzhou Molcore Biopharmatech Co.,Ltd 400-711-5280 86-571-81025280
sales@molcore.com China 9967 58
Sichuan BaiPeng Biotechnology Co., Ltd. 028-65791793 18140026355
568470422@qq.com China 10020 58

  • 1-Methylindoline-4-carboxylic acid
  • 1H-Indole-4-carboxylic acid, 2,3-dihydro-1-methyl-
  • 168899-63-6
Copyright 2019 ? ChemicalBook. All rights reserved